Your browser doesn't support javascript.
loading
Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses.
Abd Hamid, Megat; Colin-York, Huw; Khalid-Alham, Nasullah; Browne, Molly; Cerundolo, Lucia; Chen, Ji-Li; Yao, Xuan; Rosendo-Machado, Samara; Waugh, Craig; Maldonado-Perez, David; Bowes, Emma; Verrill, Clare; Cerundolo, Vincenzo; Conlon, Christopher P; Fritzsche, Marco; Peng, Yanchun; Dong, Tao.
Afiliação
  • Abd Hamid M; Chinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Colin-York H; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Khalid-Alham N; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Browne M; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, United Kingdom.
  • Cerundolo L; Oxford National Institute of Health Research (NIHR) Biomedical Research Centre, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Chen JL; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Yao X; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Rosendo-Machado S; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Waugh C; Chinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Maldonado-Perez D; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Bowes E; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Verrill C; Flow Cytometry Facility, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Cerundolo V; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Conlon CP; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Fritzsche M; Oxford National Institute of Health Research (NIHR) Biomedical Research Centre, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Peng Y; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
  • Dong T; Chinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Cancer Immunol Res ; 8(2): 203-216, 2020 02.
Article em En | MEDLINE | ID: mdl-31771983
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Antígenos CD / Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos / Cadeias alfa de Integrinas / Neoplasias Pulmonares / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Antígenos CD / Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos / Cadeias alfa de Integrinas / Neoplasias Pulmonares / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article